-60%

est. 2Y upside i

HealthcareSeries B

Rebuilding healthcare with AI at the core

Rank

#3395

Sector

Healthcare Technology

Est. Liquidity

~4Y

Data Quality

Data: Medium

The expected equity upside over 2 years is -60%, driven by a stretched entry valuation (18.6x revenue) and high preference overhang ($95.6M).

Last updated: July 3, 2026

Bull (25%)+13%

Exit at 15x revenue (~$530M) via IPO or acquisition, yielding $434M to common stock. Net of 15% dilution, equity appreciates 12.6%.

Base (30%)-60%

Exit at 8x revenue (~$282M), common gets $187M after preference. Dilution reduces further to -60.1%.

Bear (45%)-100%

Multiple compresses to 4x revenue (~$141M) or lower; common stock value nearly wiped out after preferences and dilution.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Funding Intensity

2810%

Total preferred funding of $95.6M represents 28% of the current valuation, creating a significant overhang that must be overcome for common stock to realize value.

Dilution Risk

moderate

Though profitable, the company may still raise capital for growth, likely resulting in 10-15% dilution over 2 years.

Secondary Liquidity

none

No secondary market transactions are reported; any liquidity event is uncertain.

Questions to Ask at the Interview

Strategic questions based on Akido Labs's data — designed to show you've done your homework.

  • 1

    How will Akido Labs differentiate its clinical AI platform against the scale and resources of Google Health and Microsoft DAX?

  • 2

    What is the unit economics of your care provider network, and how do they improve with scale?

  • 3

    Given the high preference overhang and no secondary market, what is the expected timeline to liquidity, and have you considered alternative structures like early exercise or Tender Offers?

Community

Valuation Sentiment

Our model estimates -60% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.